ODI PHARMA AB Cash Flow-to-Debt Ratio
ODI PHARMA AB cash flow-to-debt ratio. ODI PHARMA AB (6OD) has a Cash Flow-to-Debt Ratio of 0.12x as of June 2026, meaning its operating cash flow of €364.19K could theoretically repay 0% of its total liabilities (€2.93 Million) in one year. Check cash flow quality index of ODI PHARMA AB to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ODI PHARMA AB (2022–2026)
Cash flow-to-debt ratio of ODI PHARMA AB from 2022 to 2026. Historical debt coverage capacity for ODI PHARMA AB across 5 annual periods. Check 6OD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
ODI PHARMA AB Cash Flow-to-Debt Ratio by Year (2022–2026)
ODI PHARMA AB cash flow-to-debt ratio by year from 2022 to 2026. Year-by-year debt coverage analysis for ODI PHARMA AB. For the full cash flow conversion analysis, see ODI PHARMA AB (6OD) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 1.56x | €4.58 Million | €2.93 Million | ▲ +298.0% |
| 2025 | -0.79x | €-3.31 Million | €4.19 Million | ▼ -111.2% |
| 2024 | -0.37x | €-3.82 Million | €10.23 Million | ▲ +58.9% |
| 2023 | -0.91x | €-5.10 Million | €5.61 Million | ▲ +84.8% |
| 2022 | -5.97x | €-7.37 Million | €1.24 Million | — |